Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

99
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
99
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

97
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
97
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

185
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
185
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

109
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
109
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

813
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
813
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

3.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ring of fire cells: plasma cell-predominant relapse of Waldenström macroglobulinemia.

Blood·2026
Same author

Mass Density Characterization of Hydrogel-Based Systems Inoculated with Bacterial Strains and Dose-Response Performance of <i>Escherichia coli</i> Inoculation.

Journal of functional biomaterials·2025
Same author

Development and Validation of Monte Carlo Methods for Converay: A Proof-of-Concept Study.

Cancers·2025
Same author

Development of a Multiple Temperature Sensors Device for the Characterization, Control and Monitoring of Microbiological Incubators.

Sensors (Basel, Switzerland)·2024
Same author

A Machine Learning based model for a Dose Point Kernel calculation.

Research square·2023
Same author

Dosimetry Effects Due to the Presence of Fe Nanoparticles for Potential Combination of Hyperthermic Cancer Treatment with MRI-Based Image-Guided Radiotherapy.

International journal of molecular sciences·2023
Same journal

It's PET but not as we know it: radiation protection considerations when using a novel specimen PET-CT scanner during tumour resections for urology and head & neck patients.

EJNMMI physics·2026
Same journal

Data-efficient unsupervised deep learning deformable SPECT/CT registration framework for voxel-level radionuclide therapy dosimetry: validation using clinical <sup>131</sup>I DTC therapy data.

EJNMMI physics·2026
Same journal

Impact of reduced <sup>18</sup>F-MK6240 PET/MR acquisition duration on image quality and tau pathology assessment in patients with cognitive impairment.

EJNMMI physics·2026
Same journal

Optimising [Formula: see text] PET imaging for dosimetry in SIRT: insights from phantom and simulation studies on the Discovery MI scanner.

EJNMMI physics·2026
Same journal

Denoising of 4D dynamic PET images using spatiotemporal regularization with integrated temporal restoration (SPRINTER).

EJNMMI physics·2026
Same journal

Limitations in diagnostics and quantification of small lesions with low uptake in the clinical context of prostate <sup>18</sup>F/<sup>68</sup>Ga-PSMA PET/MRI.

EJNMMI physics·2026
See all related articles

Related Experiment Video

Updated: Jul 25, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.8K

A machine learning-based model for a dose point kernel calculation.

Ignacio Scarinci1,2, Mauro Valente3,4,5, Pedro Pérez1,2

  • 1Instituto de Física Enrique Gaviola (IFEG), CONICET, Av. Medina Allende s/n, 5000, Córdoba, Argentina.

EJNMMI Physics
|June 26, 2023
PubMed
Summary
This summary is machine-generated.

A new machine learning model accurately predicts dose point kernels (DPKs) for nuclear medicine dosimetry. This approach enables faster, reliable patient-specific absorbed dose calculations for treatments like radioembolization.

Keywords:
Beta emittersDose point kernelInternal dosimetryMachine learning

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K

Related Experiment Videos

Last Updated: Jul 25, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.8K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K

Area of Science:

  • Medical Physics
  • Nuclear Medicine
  • Computational Science

Background:

  • Accurate absorbed dose calculation is crucial for effective nuclear medicine treatments.
  • Dose point kernels (DPKs) are essential for convolution-based absorbed dose calculations.
  • Current methods for DPK generation can be computationally intensive.

Purpose of the Study:

  • To develop and implement a multi-target regressor approach for generating DPKs for monoenergetic sources.
  • To create a model for obtaining DPKs for beta emitters used in nuclear medicine.
  • To validate the model's accuracy in patient-specific dosimetry.

Main Methods:

  • Calculated DPKs for monoenergetic electron sources using FLUKA Monte Carlo (MC) code.
  • Employed Regressor Chains (RC) with regularization/shrinkage models.
  • Assessed beta emitter scaled DPKs (sDPKs) against reference data and applied them to patient-specific Voxel Dose Kernel (VDK) calculations.

Main Results:

  • Machine learning models accurately predicted sDPKs for monoenergetic and beta emitters, with mean average percentage errors below [Formula: see text].
  • Patient-specific dosimetry calculations showed differences below [Formula: see text] compared to full MC simulations.
  • The developed models demonstrated a promising capacity for predicting DPKs across various materials and energies.

Conclusions:

  • An ML model was successfully developed for nuclear medicine dosimetry calculations.
  • The model accurately predicts sDPKs for beta-emitting radionuclides, enabling reliable patient-specific absorbed dose distributions.
  • The approach significantly reduces computation time for dosimetry, enhancing clinical applicability.